<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PLD5 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>PLD5</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q8N7P1" target="_blank" class="term-link">
                        Q8N7P1
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Aliases:</span>
                <div class="aliases">
                    
                    <span class="badge">Inactive phospholipase D5</span>
                    
                    <span class="badge">Inactive PLD 5</span>
                    
                    <span class="badge">Inactive choline phosphatase 5</span>
                    
                    <span class="badge">PLDc</span>
                    
                    <span class="badge">Phospholipase D family member 5</span>
                    
                </div>
            </div>
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "PLD5";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q8N7P1" data-a="DESCRIPTION: Phospholipase D family member 5 (PLD5) is a poorly..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>Phospholipase D family member 5 (PLD5) is a poorly characterized member of the PLD superfamily. Despite containing the characteristic PLD phosphodiesterase domains with HKD motifs, PLD5 is considered catalytically inactive as a phospholipase because it lacks conserved active site residues required for phospholipid hydrolysis. UniProt explicitly names this protein &#34;Inactive phospholipase D5&#34;. The protein is a type II single-pass transmembrane protein (~536 amino acids, ~61 kDa) that lacks the PX and PH domains found in classical PLD1/PLD2. Expression is enriched in brain and choroid plexus. Subcellular localization studies suggest mitochondrial localization in some cell types. While related family members PLD3/PLD4 have been shown to function as 5&#39; exonucleases in endolysosomes rather than lipases, no enzymatic activity has been demonstrated for PLD5. The molecular function of PLD5 remains undefined - it may act as a pseudoenzyme/scaffold, have an unknown substrate, or possess a non-catalytic regulatory role. Overexpression in prostate cancer promotes proliferation and is regulated by miR-145-5p. PLD5 is distinct from PLD6/MitoPLD which has cardiolipin hydrolase activity.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003824" target="_blank" class="term-link">
                                    GO:0003824
                                </a>
                            </span>
                            <span class="term-label">catalytic activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q8N7P1" data-a="GO:0003824" data-r="GO_REF:0000002" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is based on InterPro domain IPR001736 (PLipase_D/transphosphatidylase) which is present in PLD5. However, authoritative reviews and UniProt explicitly state that PLD5 lacks the conserved HKD active sites and is catalytically inactive.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PLD5 is explicitly designated as &#34;Inactive phospholipase D5&#34; by UniProt due to degenerate HKD catalytic motifs. Multiple reviews confirm PLD5 lacks phospholipase activity. Nelson and Frohman (2015) state PLD5 has &#34;no catalytic activity&#34; as a lipase. Bozatzi and Sapkota (2018) confirm PLD5 is &#34;catalytically inactive&#34; due to lacking HKD motifs. A 2023 structural analysis states &#34;Little is known about PLD5, and it is even unclear if it is active as an enzyme.&#34; While the protein contains the PLD domain architecture, this IEA annotation incorrectly implies active catalytic function. The presence of a catalytic domain does not guarantee enzymatic activity - many pseudoenzymes exist.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PLD5/PLD5-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">In contrast to other members of the family, it lacks the conserved active sites, suggesting that it has no phospholipase activity.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PLD5/PLD5-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">PLD5 catalytic status: Authoritative reviews consistently report that human PLD5 lacks catalytic activity as a lipase because it lacks the requisite conserved HKD catalytic motifs; thus PLD5 is considered catalytically inactive within the classical PLD reaction framework</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PLD5/PLD5-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">PLD5 is often referred to as an &#34;inactive phospholipase D5&#34; in databases</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8N7P1" data-a="GO:0016020" data-r="GO_REF:0000044" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PLD5 is a single-pass type II transmembrane protein with a predicted transmembrane helix at residues 69-89. UniProt confirms membrane localization, and HPA data suggests mitochondrial membrane localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While the general membrane annotation is correct, more specific localization data is available. Human Protein Atlas immunofluorescence data shows PLD5 is primarily localized to mitochondria in U-2 OS and A-549 cell lines. The protein has a single transmembrane domain consistent with a type II membrane topology. More specific annotations for intracellular membrane or mitochondrial membrane would be more informative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016021" target="_blank" class="term-link">
                                    integral component of membrane
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031966" target="_blank" class="term-link">
                                    mitochondrial membrane
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PLD5/PLD5-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PLD5/PLD5-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Data from the Human Protein Atlas indicate PLD5 is primarily localized to mitochondria in cultured human cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>PLD5 molecular function is undefined. The protein contains PLD phosphodiesterase domains but lacks conserved active site residues for phospholipase activity. It may function as a pseudoenzyme with scaffolding or regulatory roles rather than catalytic activity. The protein contains two PLDc domains that could potentially bind substrates or interaction partners without catalyzing reactions. No specific binding partners or activities have been experimentally validated. Unlike PLD3/PLD4 which have been shown to have nuclease activity, PLD5 has no demonstrated enzymatic activity of any kind.</h3>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="FUNCTION: PLD5 molecular function is undefined. The protein ..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003674" target="_blank" class="term-link">
                            molecular_function
                        </a>
                    </span>
                </div>
                

                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031966" target="_blank" class="term-link">
                                mitochondrial membrane
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016021" target="_blank" class="term-link">
                                integral component of membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/PLD5/PLD5-uniprot.txt
                            
                        </span>
                        
                        <div class="finding-text">In contrast to other members of the family, it lacks the conserved active sites, suggesting that it has no phospholipase activity.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/PLD5/PLD5-deep-research-openai.md
                            
                        </span>
                        
                        <div class="finding-text">Little is known about PLD5, and it is even unclear if it is active as an enzyme</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/PLD5/PLD5-uniprot.txt
                        
                    </span>
                </div>
                
                <div class="reference-title">UniProtKB entry for human PLD5 (Inactive phospholipase D5)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Explicitly named &#34;Inactive phospholipase D5&#34; with caution note about lacking conserved active sites</div>
                        
                        <div class="finding-text">"RecName: Full=Inactive phospholipase D5"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Single-pass transmembrane protein, 536 amino acids</div>
                        
                        <div class="finding-text">"TRANSMEM        69..89"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Contains two PLD phosphodiesterase domains</div>
                        
                        <div class="finding-text">"DOMAIN          215..242 ... PLD phosphodiesterase 1 ... DOMAIN          434..460 ... PLD phosphodiesterase 2"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Expression enriched in brain and choroid plexus</div>
                        
                        <div class="finding-text">"HPA; ENSG00000180287; Group enriched (brain, choroid plexus)."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/PLD5/PLD5-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research report on PLD5 from Falcon/Edison Scientific Literature</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PLD5 lacks catalytic activity as a lipase due to missing HKD motifs</div>
                        
                        <div class="finding-text">"PLD5 catalytic status: Authoritative reviews consistently report that human PLD5 lacks catalytic activity as a lipase because it lacks the requisite conserved HKD catalytic motifs; thus PLD5 is considered catalytically inactive within the classical PLD reaction framework"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PLD5 may have non-lipase activity similar to PLD3/PLD4 which are nucleases</div>
                        
                        <div class="finding-text">"some paralogs (e.g., PLD3) possess nuclease activity rather than phospholipase activity, underscoring divergent functions within the family"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PLD5 overexpression promotes cancer cell proliferation</div>
                        
                        <div class="finding-text">"PLD5 overexpression promotes proliferation, migration, invasion, and metastasis, whereas miR-145-5p mimics suppress these PLD5-driven oncogenic phenotypes"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/PLD5/PLD5-deep-research-openai.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research report on PLD5 from OpenAI o3-deep-research</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PLD5 is a transmembrane protein with type II membrane topology</div>
                        
                        <div class="finding-text">"PLD5 contains a short N-terminal segment, a single-pass transmembrane region, and a large C-terminal region comprising two PLD phosphodiesterase domains"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PLD5 localizes to mitochondria in cultured cells</div>
                        
                        <div class="finding-text">"Data from the Human Protein Atlas indicate PLD5 is primarily localized to mitochondria in cultured human cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">No enzymatic activity has been demonstrated for PLD5</div>
                        
                        <div class="finding-text">"Little is known about PLD5, and it is even unclear if it is active as an enzyme"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does PLD5 have any enzymatic activity (e.g., nuclease activity like PLD3/PLD4, or other non-phospholipase activity)?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="Q: Does PLD5 have any enzymatic activity (e.g., nucle..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the functional significance of PLD5 mitochondrial localization?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="Q: What is the functional significance of PLD5 mitoch..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does PLD5 function as a pseudoenzyme/scaffold by binding substrates or regulators without catalyzing reactions?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="Q: Does PLD5 function as a pseudoenzyme/scaffold by b..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What are the binding partners of PLD5?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="Q: What are the binding partners of PLD5?..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Why is PLD5 expression enriched in brain/choroid plexus?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="Q: Why is PLD5 expression enriched in brain/choroid p..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> In vitro biochemical assays testing PLD5 for nuclease activity (as seen in PLD3/PLD4) and other potential enzymatic activities</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: PLD5 may have nuclease activity similar to its paralogs PLD3/PLD4</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: biochemical assay</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="EXPERIMENT: In vitro biochemical assays testing PLD5 for nucle..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Co-immunoprecipitation followed by mass spectrometry to identify PLD5 protein interaction partners</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: PLD5 may function as a scaffold by interacting with other proteins</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: proteomics</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="EXPERIMENT: Co-immunoprecipitation followed by mass spectromet..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> CRISPR knockout of PLD5 in neuronal or choroid plexus cell lines to assess phenotypes</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Loss of PLD5 may reveal its function in brain-enriched tissues</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: functional genomics</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="EXPERIMENT: CRISPR knockout of PLD5 in neuronal or choroid ple..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Structural studies (X-ray crystallography or cryo-EM) to determine if PLD5 active site can accommodate substrates</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Structural analysis may reveal whether PLD5 can bind substrates despite lacking catalytic activity</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: structural biology</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="EXPERIMENT: Structural studies (X-ray crystallography or cryo-..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Submitochondrial fractionation to determine precise membrane localization (outer vs inner mitochondrial membrane)</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Precise localization may suggest functional context</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: cell biology</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8N7P1" data-a="EXPERIMENT: Submitochondrial fractionation to determine precis..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(PLD5-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8N7P1" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-14T17:16:00.734854'<br />
end_time: '2025-12-14T17:22:17.471234'<br />
duration_seconds: 376.74<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: PLD5<br />
  gene_symbol: PLD5<br />
  uniprot_accession: Q8N7P1<br />
  protein_description: 'RecName: Full=Inactive phospholipase D5; Short=Inactive PLD<br />
    5; AltName: Full=Inactive choline phosphatase 5; AltName: Full=Inactive phosphatidylcholine-hydrolyzing<br />
    phospholipase D5; AltName: Full=PLDc;'<br />
  gene_info: Name=PLD5;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the phospholipase D family. .<br />
  protein_domains: Diverse_PLD-related. (IPR050874); PLDc_3. (IPR032803); PLipase_D/transphosphatidylase.<br />
    (IPR001736); PLDc_3 (PF13918)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 14</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N7P1</li>
<li><strong>Protein Description:</strong> RecName: Full=Inactive phospholipase D5; Short=Inactive PLD 5; AltName: Full=Inactive choline phosphatase 5; AltName: Full=Inactive phosphatidylcholine-hydrolyzing phospholipase D5; AltName: Full=PLDc;</li>
<li><strong>Gene Information:</strong> Name=PLD5;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the phospholipase D family. .</li>
<li><strong>Key Domains:</strong> Diverse_PLD-related. (IPR050874); PLDc_3. (IPR032803); PLipase_D/transphosphatidylase. (IPR001736); PLDc_3 (PF13918)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "PLD5" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'PLD5' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>PLD5</strong> (gene ID: PLD5, UniProt: Q8N7P1) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N7P1</li>
<li><strong>Protein Description:</strong> RecName: Full=Inactive phospholipase D5; Short=Inactive PLD 5; AltName: Full=Inactive choline phosphatase 5; AltName: Full=Inactive phosphatidylcholine-hydrolyzing phospholipase D5; AltName: Full=PLDc;</li>
<li><strong>Gene Information:</strong> Name=PLD5;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the phospholipase D family. .</li>
<li><strong>Key Domains:</strong> Diverse_PLD-related. (IPR050874); PLDc_3. (IPR032803); PLipase_D/transphosphatidylase. (IPR001736); PLDc_3 (PF13918)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "PLD5" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'PLD5' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>PLD5</strong> (gene ID: PLD5, UniProt: Q8N7P1) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan<br />
- Verify identity, organism, and family/domain membership for human PLD5 (Q8N7P1).<br />
- Extract PLD5-specific evidence on catalytic motifs/activity, subcellular localization, tissue expression (esp. brain), molecular roles/pathways, regulation, and disease associations.<br />
- Prioritize recent (2023‚Äì2024) reviews for PLD family context and reconcile any conflicting annotations on PLD5.<br />
- Synthesize applications/implementations, expert opinions, and quantitative findings where available; clearly state unknowns.<br />
- Provide a fully cited research report with URLs and publication dates.</p>
<p>Comprehensive Research Report: Human PLD5 (UniProt Q8N7P1)</p>
<p>Gene/protein verification and family placement<br />
- Identity and organism: The target is human PLD5 (phospholipase D family member 5), UniProt Q8N7P1, in Homo sapiens. Multiple authoritative reviews place PLD5 within the mammalian phospholipase D (PLD) superfamily that comprises PLD1‚ÄìPLD6 (review context, human-focused) (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 1-3). A biochemical review of ‚Äúpseudo-PLD‚Äù domains also summarizes the human PLD family membership (Jun 2018; https://doi.org/10.1042/BST20160277) (bozatzi2018thefam83family pages 1-2).<br />
- Domain/family alignment: PLD family members characteristically harbor HKD catalytic motifs (HXKX4D), typically in two copies, and fall within the broader PLD superfamily fold (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 1-3). Reviews covering PLD family architecture include PLD5 in the six-member human set and discuss HKD motif presence/absence as a key functional discriminator (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).</p>
<p>Key concepts and definitions (current understanding)<br />
- Canonical PLD reaction: Active phospholipase D enzymes hydrolyze phosphatidylcholine to choline and phosphatidic acid (PA). In the presence of primary alcohols, they catalyze transphosphatidylation to form phosphatidylalcohols, a property exploited to measure PLD activity in cells (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 1-3).<br />
- PLD5 catalytic status: Authoritative reviews consistently report that human PLD5 lacks catalytic activity as a lipase because it lacks the requisite conserved HKD catalytic motifs; thus PLD5 is considered catalytically inactive within the classical PLD reaction framework (Jun 2018; https://doi.org/10.1042/BST20160277; Dec 2015; https://doi.org/10.1194/jlr.R059220) (bozatzi2018thefam83family pages 1-2, nelson2015physiologicalandpathophysiological pages 1-3).<br />
- Family nuance: Recent PLD superfamily overviews emphasize that not all HKD-containing proteins are catalytically active phospholipases; some paralogs (e.g., PLD3) possess nuclease activity rather than phospholipase activity, underscoring divergent functions within the family and cautioning against motif-only inference (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).</p>
<p>Domain architecture and catalytic motifs<br />
- HKD motifs: PLD catalytic function generally requires two HKD motifs within a single polypeptide. PLD5 is described as lacking these motifs and therefore being catalytically inactive as a phospholipase (Jun 2018; https://doi.org/10.1042/BST20160277; Dec 2015; https://doi.org/10.1194/jlr.R059220) (bozatzi2018thefam83family pages 1-2, nelson2015physiologicalandpathophysiological pages 1-3).<br />
- Reconciling literature: A 2024 review catalogs PLD family members and summarizes that HKD motif presence does not guarantee activity, and that some isoforms are HKD-containing but catalytically inactive or may lack one subdomain; however, it does not present experimental phospholipase activity for PLD5, and it aligns with earlier consensus that PLD5 has not been validated as an active phospholipase (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).</p>
<p>Catalytic activity (experimental evidence)<br />
- No confirmed phospholipase activity: Reviews explicitly state PLD5 has ‚Äúno catalytic activity‚Äù as a lipase (Dec 2015; https://doi.org/10.1194/jlr.R059220) and ‚Äúis catalytically inactive‚Äù due to lacking HKD motifs (Jun 2018; https://doi.org/10.1042/BST20160277) (nelson2015physiologicalandpathophysiological pages 1-3, bozatzi2018thefam83family pages 1-2).<br />
- Non-lipase activities: While other PLD family members (e.g., PLD3) have been demonstrated to have nuclease activity rather than phospholipase activity, there is currently no specific experimental demonstration of an alternative enzymatic activity for PLD5 (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).</p>
<p>Cellular/subcellular localization and tissue expression<br />
- Subcellular localization: Specific subcellular localization of human PLD5 has not been resolved in the curated reviews used here. In contrast, PLD3/PLD4 are type II transmembrane proteins in the secretory pathway and PLD6 is mitochondrial, but comparable experimental localization for PLD5 was not reported (Jun 2018; https://doi.org/10.1042/BST20160277) (bozatzi2018thefam83family pages 1-2).<br />
- Tissue expression: Definitive, experimentally supported tissue expression patterns for PLD5 (e.g., GTEx brain enrichment) were not identified in the retrieved, citable sources. Some studies discuss PLD5 in disease-tissue contexts (see below), but broad quantitative normal-tissue expression remains insufficiently characterized in the present evidence set (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 1-3).</p>
<p>Molecular function and pathways<br />
- Given lack of confirmed phospholipase activity, PLD5‚Äôs molecular function remains incompletely defined. By family context, PLD proteins (active isoforms) generate PA, influencing membrane dynamics, vesicle trafficking, and signaling; however, there is no direct evidence that PLD5 participates in PA signaling as a catalytic source of PA (Dec 2015; https://doi.org/10.1194/jlr.R059220; Jun 2018; https://doi.org/10.1042/BST20160277) (nelson2015physiologicalandpathophysiological pages 1-3, bozatzi2018thefam83family pages 1-2).<br />
- Emerging view from recent reviews: The 2024 review reiterates divergent functions within the PLD family and highlights the caution that assignment of catalytic roles to lesser-characterized members like PLD5 should await direct biochemical/functional data (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).</p>
<p>Regulation and disease associations<br />
- Cancer regulation by miRNA: A primary study in human prostate cancer demonstrates that miR-145-5p directly targets PLD5 (3‚Ä≤ UTR reporter validation). In prostate cancer cell lines and xenograft models, PLD5 overexpression promotes proliferation, migration, invasion, and metastasis, whereas miR-145-5p mimics suppress these PLD5-driven oncogenic phenotypes and increase apoptosis. This establishes post-transcriptional regulation of PLD5 by miR-145-5p and supports a pro-tumorigenic role of PLD5 expression in this context (Jan 2021; https://doi.org/10.1080/21655979.2021.1945361) (liu2021micrornamir1455pinhibits pages 1-3, liu2021micrornamir1455pinhibits pages 3-5).<br />
- Human genetic associations: Earlier review summarizing human studies notes PLD5 polymorphisms associated with tumor progression risk in cutaneous and uterine leiomyomatosis, and a borderline association signal for autism spectrum disorder in a genotyping study of 1,558 families‚Äîinterpreted as suggestive and requiring further validation (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 1-3, nelson2015physiologicalandpathophysiological pages 10-12).</p>
<p>Recent developments and latest research (2023‚Äì2024 emphasis)<br />
- Family-level insights: A 2024 review of PLD in neurodegenerative and neuroimmune diseases underscores that the human PLD family contains catalytically diverse members and that some paralogs lack or diverge in HKD motifs; this review continues to list PLD5 as a poorly characterized family member without validated phospholipase activity, highlighting the need for direct functional studies (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).<br />
- Implications from related family members: The recognition that PLD3 acts as a nuclease rather than a phospholipase refocuses attention on noncanonical roles within the family and cautions against motif-based assumptions for PLD5, but no new 2023‚Äì2024 experimental activity/localization data specific to PLD5 were identified in our evidence set (Mar 2024; https://doi.org/10.1155/2024/6681911) (zhang2024phospholipaseda pages 1-2).</p>
<p>Current applications and real-world implementations<br />
- Oncology research: The miR-145-5p‚ÄîPLD5 axis in prostate cancer offers a potential therapeutic angle (restoring miR-145-5p or inhibiting PLD5 expression/function) that reduced proliferation/metastasis in preclinical models, though no clinical trials targeting PLD5 were found in the present evidence (Jan 2021; https://doi.org/10.1080/21655979.2021.1945361) (liu2021micrornamir1455pinhibits pages 1-3, liu2021micrornamir1455pinhibits pages 3-5).<br />
- PLD inhibitors: While small-molecule PLD inhibitors exist and are under development (largely targeting PLD1/PLD2), there is no evidence of catalytic inhibition strategies being applicable to PLD5 specifically, given the lack of confirmed enzymatic activity (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 1-3).</p>
<p>Expert opinions, analysis, and consensus<br />
- Consensus on inactivity: Cross-review agreement (2015, 2018) supports PLD5 as catalytically inactive due to lacking HKD motifs. The most recent 2024 review maintains PLD5 as insufficiently characterized and does not overturn the inactivity consensus, instead emphasizing the broader functional diversity in the family and the need for direct testing (Dec 2015; https://doi.org/10.1194/jlr.R059220; Jun 2018; https://doi.org/10.1042/BST20160277; Mar 2024; https://doi.org/10.1155/2024/6681911) (nelson2015physiologicalandpathophysiological pages 1-3, bozatzi2018thefam83family pages 1-2, zhang2024phospholipaseda pages 1-2).<br />
- Disease implications remain preliminary: Genetic associations summarized in review literature are suggestive but not definitive; the clearest experimental disease relevance to date is the miR-145-5p‚ÄìPLD5 axis in prostate cancer models (Dec 2015; https://doi.org/10.1194/jlr.R059220; Jan 2021; https://doi.org/10.1080/21655979.2021.1945361) (nelson2015physiologicalandpathophysiological pages 10-12, liu2021micrornamir1455pinhibits pages 1-3, liu2021micrornamir1455pinhibits pages 3-5).</p>
<p>Relevant statistics and data<br />
- Prostate cancer models: The 2021 study reports significant suppression of proliferation/migration/invasion upon miR-145-5p overexpression and reversal of PLD5 overexpression phenotypes in vitro and inhibition of metastasis in vivo; the study validates direct binding via dual-luciferase reporters containing the PLD5 3‚Ä≤ UTR (Jan 2021; https://doi.org/10.1080/21655979.2021.1945361) (liu2021micrornamir1455pinhibits pages 1-3, liu2021micrornamir1455pinhibits pages 3-5). (Note: The study is experimental and provides effect-size data in figures; the qualitative summary here is derived from the reported results.)<br />
- Human genetics: Association signals for PLD5 polymorphisms with leiomyomatosis progression and borderline ASD association are summarized in review form and should be interpreted cautiously pending replication (Dec 2015; https://doi.org/10.1194/jlr.R059220) (nelson2015physiologicalandpathophysiological pages 10-12).</p>
<p>Gaps and recommendations<br />
- Localization and expression: Robust, direct data for human PLD5 subcellular localization and normal tissue expression (e.g., brain enrichment) were not found in the curated sources here; further targeted searches of proteomic localization atlases and GTEx/brain transcriptomics with orthogonal validation are recommended.<br />
- Function: Given the absence of demonstrated phospholipase activity, targeted biochemical assays for alternative activities (e.g., nucleic acid metabolizing) or nonenzymatic roles, along with cellular phenotyping upon knockdown/overexpression, are priorities.<br />
- Disease relevance: Beyond prostate cancer models, systematic interrogation of PLD5 expression/regulation across cancers and neurodevelopmental/neuropsychiatric conditions (with replication and mechanistic follow-up) is needed.</p>
<p>Conclusion<br />
Human PLD5 (Q8N7P1) is a poorly characterized member of the PLD superfamily. Consensus reviews indicate it lacks the HKD catalytic motifs necessary for phospholipase activity and is therefore considered catalytically inactive as a lipase. No definitive subcellular localization or normal-tissue expression atlas could be confirmed in the present evidence. The clearest experimental evidence for biological relevance is in prostate cancer, where miR-145-5p directly targets PLD5 and suppresses PLD5-driven oncogenic phenotypes in vitro and in vivo. Family-level advances in 2024 underscore functional diversity among PLD paralogs but do not provide new PLD5-specific functional activity. Overall, PLD5 remains an understudied protein with suggestive disease links that warrant targeted experimental characterization (Dec 2015; https://doi.org/10.1194/jlr.R059220; Jun 2018; https://doi.org/10.1042/BST20160277; Mar 2024; https://doi.org/10.1155/2024/6681911; Jan 2021; https://doi.org/10.1080/21655979.2021.1945361) (nelson2015physiologicalandpathophysiological pages 1-3, bozatzi2018thefam83family pages 1-2, zhang2024phospholipaseda pages 1-2, liu2021micrornamir1455pinhibits pages 1-3, liu2021micrornamir1455pinhibits pages 3-5, nelson2015physiologicalandpathophysiological pages 10-12).</p>
<p>References</p>
<ol>
<li>
<p>(nelson2015physiologicalandpathophysiological pages 1-3): Rochelle K. Nelson and Michael A. Frohman. Physiological and pathophysiological roles for phospholipase d. Journal of Lipid Research, 56:2229-2237, Dec 2015. URL: https://doi.org/10.1194/jlr.r059220, doi:10.1194/jlr.r059220. This article has 125 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(bozatzi2018thefam83family pages 1-2): Polyxeni Bozatzi and Gopal P. Sapkota. The fam83 family of proteins: from pseudo-plds to anchors for ck1 isoforms. Biochemical Society Transactions, 46:761-771, Jun 2018. URL: https://doi.org/10.1042/bst20160277, doi:10.1042/bst20160277. This article has 54 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(zhang2024phospholipaseda pages 1-2): Weiwei Zhang, Feiqi Zhu, Jie Zhu, and Kangding Liu. Phospholipase d, a novel therapeutic target contributes to the pathogenesis of neurodegenerative and neuroimmune diseases. Analytical Cellular Pathology (Amsterdam), Mar 2024. URL: https://doi.org/10.1155/2024/6681911, doi:10.1155/2024/6681911. This article has 6 citations.</p>
</li>
<li>
<p>(liu2021micrornamir1455pinhibits pages 1-3): Juanni liu, Junhai Li, Yongtu Ma, Changbao Xu, Yigang Wang, and Yanfeng He. Microrna mir-145-5p inhibits phospholipase d 5 (pld5) to downregulate cell proliferation and metastasis to mitigate prostate cancer. Bioengineered, 12:3240-3251, Jan 2021. URL: https://doi.org/10.1080/21655979.2021.1945361, doi:10.1080/21655979.2021.1945361. This article has 33 citations.</p>
</li>
<li>
<p>(liu2021micrornamir1455pinhibits pages 3-5): Juanni liu, Junhai Li, Yongtu Ma, Changbao Xu, Yigang Wang, and Yanfeng He. Microrna mir-145-5p inhibits phospholipase d 5 (pld5) to downregulate cell proliferation and metastasis to mitigate prostate cancer. Bioengineered, 12:3240-3251, Jan 2021. URL: https://doi.org/10.1080/21655979.2021.1945361, doi:10.1080/21655979.2021.1945361. This article has 33 citations.</p>
</li>
<li>
<p>(nelson2015physiologicalandpathophysiological pages 10-12): Rochelle K. Nelson and Michael A. Frohman. Physiological and pathophysiological roles for phospholipase d. Journal of Lipid Research, 56:2229-2237, Dec 2015. URL: https://doi.org/10.1194/jlr.r059220, doi:10.1194/jlr.r059220. This article has 125 citations and is from a peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>nelson2015physiologicalandpathophysiological pages 1-3</li>
<li>zhang2024phospholipaseda pages 1-2</li>
<li>nelson2015physiologicalandpathophysiological pages 10-12</li>
<li>https://doi.org/10.1194/jlr.R059220</li>
<li>https://doi.org/10.1042/BST20160277</li>
<li>https://doi.org/10.1155/2024/6681911</li>
<li>https://doi.org/10.1042/BST20160277;</li>
<li>https://doi.org/10.1194/jlr.R059220;</li>
<li>https://doi.org/10.1080/21655979.2021.1945361</li>
<li>https://doi.org/10.1155/2024/6681911;</li>
<li>https://doi.org/10.1194/jlr.r059220,</li>
<li>https://doi.org/10.1042/bst20160277,</li>
<li>https://doi.org/10.1155/2024/6681911,</li>
<li>https://doi.org/10.1080/21655979.2021.1945361,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(PLD5-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8N7P1" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-03T23:37:43.725500'<br />
end_time: '2025-11-03T23:37:43.729515'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: Q8N7P1<br />
  gene_symbol: PLD5<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 72</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene PLD5 (Q8N7P1) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="pld5-phospholipase-d-family-member-5-overview-and-function">PLD5 (Phospholipase D Family Member 5) ‚Äì Overview and Function</h1>
<h2 id="family-and-structural-features">Family and Structural Features</h2>
<p>PLD5 (UniProt Q8N7P1) is a member of the phospholipase D (PLD) superfamily, which are enzymes characterized by a common <strong>H(X)K(X‚ÇÑ)D</strong> (HKD) catalytic motif and activity on phosphodiester bonds (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=biochemical%20mechanism%20and%20an%20H,phosphatidylcholine%20and%20producing%20phosphatidic%20acid">academic.oup.com</a>). In humans, the PLD family comprises six genes (PLD1‚ÄìPLD6) (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=instead%20of%20aspartate%20%28HKE%29%20%2822%29,phosphatidylcholine%20and%20producing%20phosphatidic%20acid">academic.oup.com</a>). PLD5 is often referred to as an ‚Äú<strong>inactive phospholipase D5</strong>‚Äù in databases (<a href="https://www.antibodies.com/products/primary-antibodies/pld5-antibodies#:~:text=PLD5%20Antibodies%20Explore%20our%20catalog,Inactive">www.antibodies.com</a>), reflecting key differences from the classical PLDs (PLD1 and PLD2). Unlike PLD1/2, which are large cytosolic enzymes with regulatory PX and PH domains, PLD5 is a transmembrane-type PLD lacking those N-terminal PX/PH domains (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). Instead, PLD5 contains a short N-terminal segment, a single-pass transmembrane region, and a large C-terminal region comprising two PLD phosphodiesterase domains (sometimes called PLD-PDE1 and PLD-PDE2) that harbor the HKD motifs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). The human PLD5 protein is ~536 amino acids in length (~61 kDa) and contains one predicted transmembrane helix with no cleavable signal peptide, consistent with a type-II membrane protein topology (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=now%20officially%20designated%20%E2%80%9CPLD%20family,putative%20TM%20domain%20instead%20of">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>). This topology is similar to PLD3 and PLD4, which are synthesized as single-pass membrane glycoproteins and then proteolytically processed in the endolysosomal system (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=5%E2%80%B2%20exonucleases%20PLD3%20or%20PLD4,the%20hydrolysis%20of%20phosphodiester%20bonds">academic.oup.com</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Despite sharing the signature HKD motifs, <strong>PLD5‚Äôs catalytic motifs are degenerate</strong> compared to active PLDs. Notably, sequence analysis indicates that PLD5‚Äôs HKD sequences are <strong>less conserved</strong>, carrying substitutions in critical residues (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>). For example, related family member PLD3 has a mutation in the second HKD motif (H‚ÜíE substitution) and was found to lack classical PLD enzymatic activity (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=biochemical%20mechanism%20and%20an%20H,phosphatidylcholine%20and%20producing%20phosphatidic%20acid">academic.oup.com</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). Similarly, PLD4 was shown to have <strong>no phospholipase D activity</strong> in biochemical assays (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=,in%20spleen%20and%20early%20postnatal">pmc.ncbi.nlm.nih.gov</a>). PLD5 is predicted to follow this pattern ‚Äì it belongs to the ‚Äúnon-classical‚Äù or ‚ÄúHKD-superfamily‚Äù PLDs that likely do not function as typical phospholipid hydrolases (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). In summary, PLD5 is structurally a PLD family protein with the conserved domain architecture, but <strong>it diverges in key catalytic residues</strong>, suggesting a fundamentally different or inactive enzymatic function.</p>
<h2 id="catalytic-activity-and-substrate-specificity">Catalytic Activity and Substrate Specificity</h2>
<p><strong>No definitive enzymatic activity or substrate has been confirmed for PLD5 to date.</strong> The classical PLD enzymes (PLD1/2) catalyze the hydrolysis of phosphatidylcholine, generating phosphatidic acid and choline (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=instead%20of%20aspartate%20%28HKE%29%20%2822%29,phosphatidylcholine%20and%20producing%20phosphatidic%20acid">academic.oup.com</a>). In contrast, <strong>PLD5 has not been observed to catalyze this reaction</strong> and is considered catalytically inactive with respect to phospholipid hydrolysis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=family%20member%205%20,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). Early bioinformatic and mutational analyses led to the prediction that PLD5 (originally called PLDC1 in some studies) might be an <strong>inactive phosphatidylcholine phospholipase</strong> due to substitutions in the HKD motifs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>). Indeed, database annotations list PLD5 as ‚Äúinactive phosphatidylcholine-hydrolyzing phospholipase D5‚Äù or ‚Äúinactive choline phosphatase 5‚Äù (<a href="https://www.antibodies.com/products/primary-antibodies/pld5-antibodies#:~:text=PLD5%20Antibodies%20Explore%20our%20catalog,Inactive">www.antibodies.com</a>). This nomenclature implies that <strong>PLD5 does not effectively hydrolyze phosphatidylcholine or related lipids</strong> under normal conditions. Experimental support for this comes by analogy: Yoshikawa et al. (2010) demonstrated that the closely related PLD4 lacked any phospholipase activity in vitro despite containing the HKD sequences (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=,in%20spleen%20and%20early%20postnatal">pmc.ncbi.nlm.nih.gov</a>), and they noted PLD5 had even less conservation in those catalytic motifs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>). As of 2023, <strong>no known lipid substrate has been assigned to PLD5</strong>, and standard PLD assays have not shown activity. </p>
<p>Interestingly, other ‚Äúinactive‚Äù PLD family members have repurposed their catalytic domain for different substrates. For instance, <strong>PLD3 and PLD4 function as 5‚Ä≤ exonucleases</strong> that degrade single-stranded DNA and RNA in acidic endosomes/lysosomes (rather than acting on phospholipids) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=While%20crystal%20structures%20for%20RNaseT2,the%20PLD3%20sequence%20contains%20glutamate">academic.oup.com</a>). PLD6, on the other hand, is a <strong>mitochondrial cardiolipin hydrolase</strong> (‚ÄúMitoPLD‚Äù) involved in generating phosphatidic acid on the mitochondrial surface (<a href="https://eprotworkbench.apps.cloud.kbds.re.kr/hProteome-7.L-R.html#:~:text=Q8N7P1%20%20,link">eprotworkbench.apps.cloud.kbds.re.kr</a>). In these cases, the core PLD-like domain is used in unconventional chemistry ‚Äì nucleic acid cleavage for PLD3/4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>), or a unique lipid (cardiolipin) for PLD6 (<a href="https://eprotworkbench.apps.cloud.kbds.re.kr/hProteome-7.L-R.html#:~:text=Q8N7P1%20%20,link">eprotworkbench.apps.cloud.kbds.re.kr</a>). It has been hypothesized that <strong>PLD5 might likewise have a non-classical activity or a pseudoenzyme role</strong>, but this remains unproven (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). As a 2023 structural analysis of PLD3 stated, ‚Äú<strong>Little is known about PLD5, and it is even unclear if it is active as an enzyme</strong>‚Äù (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). No enzyme assays or substrates for PLD5 have been reported in the literature, and thus its primary biochemical activity (if any) is still undefined. In summary, the current understanding is that <strong>PLD5 likely does <em>not</em></strong> act as a phospholipase on common membrane lipids, and if it has any catalytic function it may target an unknown substrate or be vestigial.</p>
<h2 id="biological-role-and-pathways">Biological Role and Pathways</h2>
<p>Because a bona fide enzymatic function for PLD5 has not been identified, its <strong>biological role is largely speculative</strong>. Unlike PLD1 and PLD2, which are key players in receptor signaling (through their product phosphatidic acid) and have been implicated in diverse pathways (such as mTOR signaling, vesicle trafficking, and cell proliferation) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=transmembrane%20domain%20instead%20of%20PX,influenza%20viruses%29%2C%20and%20neurodegenerative">pmc.ncbi.nlm.nih.gov</a>), PLD5‚Äôs contributions remain elusive. By sequence and domain organization, PLD5 clusters with the <strong>‚Äúnon-classical‚Äù PLDs that lack lipid-hydrolyzing activity</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). In this regard, it is instructive to consider PLD3 and PLD4: these paralogs were eventually found to function in the endolysosomal compartment, <strong>regulating innate immunity by degrading nucleic acids</strong> and thereby preventing inappropriate activation of DNA/RNA sensors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>). Notably, PLD3/4 deficiency leads to accumulation of nucleic acid in endosomes and hyperactivation of Toll-like receptors and other sensors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>). <strong>PLD5 might have a distinct but analogous role</strong>, potentially in processing an unknown molecule or in a signaling pathway, but concrete evidence is lacking. There is <strong>no well-defined signaling or metabolic pathway</strong> that includes PLD5 as a component as of now. </p>
<p>Some clues have emerged from gene expression and phenotypic studies. PLD5 is predominantly expressed in the <strong>central nervous system</strong>, which hints at a possible neurological function. Transcript profiling indicates <strong>group-enriched expression of PLD5 in the brain, especially in the choroid plexus</strong> epithelium (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/tissue#:~:text=Tissue%20specificity%20%28RNA%29,i%7D%20Evidence%20at%20protein%20level">www.proteinatlas.org</a>). This means PLD5 mRNA is detected at higher levels in brain/choroid plexus compared to most other tissues, although it is ‚Äúdetected in some‚Äù peripheral tissues at lower levels (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/tissue#:~:text=Tissue%20specificity%20%28RNA%29,i%7D%20Evidence%20at%20protein%20level">www.proteinatlas.org</a>). Such an expression pattern suggests PLD5 could be involved in brain-specific processes or development. Consistent with this, an earlier genome-wide study flagged the <strong>PLD5 locus (1q43)</strong> in the context of autism risk (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=200150#:~:text=Bioengineered%2C%202021%20Dec,association%20to%20chromosome%201q43%20in">www.ncbi.nlm.nih.gov</a>), although the findings were not conclusive and no direct causative role was proven. It remains possible that PLD5 influences neurological pathways or brain cell physiology ‚Äì perhaps in glial cells or cerebrospinal fluid production (given choroid plexus expression) ‚Äì but further research is needed.</p>
<p>Another context where PLD5 has drawn attention is <strong>cancer biology</strong>. A recent study by Liu <em>et al.</em> (2021) identified PLD5 as a potential oncogenic factor in prostate cancer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>). In that work, PLD5 was found to be overexpressed in human prostate tumor samples, and overexpression of PLD5 in cell models <strong>promoted cancer cell proliferation, migration, and invasion</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>). The authors showed that <strong>microRNA-145-5p directly targets the 3‚Ä≤UTR of PLD5 mRNA</strong>, reducing PLD5 levels and thereby inhibiting tumor cell growth and metastasis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=3,145%20in%20prostate%20cancer">pmc.ncbi.nlm.nih.gov</a>). Notably, restoring PLD5 reversed the anti-proliferative effects of miR-145, confirming that PLD5 mediates this microRNA‚Äôs tumor-suppressive action (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>). Although the <strong>molecular mechanism by which PLD5 drives proliferation</strong> is unclear, the study reported that PLD5 overexpression correlated with up-regulation of pro-metastatic markers (such as Snail and vimentin) and activation of the Akt pathway in prostate cancer cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=incubated%20with%20anti,The%20bands%20were">pmc.ncbi.nlm.nih.gov</a>). This implies that PLD5 may interface with <strong>cell signaling pathways</strong> controlling epithelial‚Äìmesenchymal transition and survival signaling (e.g. PI3K/Akt), even if indirectly. Importantly, these findings position PLD5 as a candidate <strong>oncogene</strong> in at least some cancers, making it of interest for further exploration. However, it is worth stressing that these effects were observed in cell culture models; the <strong>precise role of PLD5 in vivo and in normal physiology remains to be determined</strong>. No specific biochemical pathway has been conclusively tied to PLD5 function yet ‚Äì current evidence is circumstantial or based on overexpression/knockdown phenotypes.</p>
<h2 id="subcellular-localization-and-mechanistic-insights">Subcellular Localization and Mechanistic Insights</h2>
<p>Given its single transmembrane domain, PLD5 is an <strong>integral membrane protein</strong> that operates within cellular compartments rather than being secreted (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/summary/gene#:~:text=Synonyms%20FLJ40773%20Gene%20description,i%7D%204">www.proteinatlas.org</a>). Both sequence-based predictions and high-throughput localization studies concur that PLD5 resides in intracellular membranes (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/summary/gene#:~:text=Synonyms%20FLJ40773%20Gene%20description,i%7D%204">www.proteinatlas.org</a>). Data from the Human Protein Atlas indicate PLD5 is <strong>primarily localized to mitochondria</strong> in cultured human cells (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=Main%20location,cycle">www.proteinatlas.org</a>). Immunofluorescence microscopy using a PLD5-specific antibody showed a mitochondrial pattern in cell lines like U-2 OS (osteosarcoma) and A-549 (lung carcinoma) (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=HPA028389%20A,i">www.proteinatlas.org</a>). This observation was ‚Äúapproved‚Äù in the HPA, suggesting the result was validated (for example, by multiple antibodies or consistency with RNA expression) (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=Main%20location,cycle">www.proteinatlas.org</a>). The mitochondrial localization of PLD5 is intriguing and may hint at a function related to this organelle. It raises the possibility that PLD5 could localize to the <strong>outer mitochondrial membrane</strong>, analogous to the tail-anchored PLD6 (MitoPLD) which also resides on mitochondria (<a href="https://eprotworkbench.apps.cloud.kbds.re.kr/hProteome-7.L-R.html#:~:text=Q8N7P1%20%20,link">eprotworkbench.apps.cloud.kbds.re.kr</a>). If PLD5 is indeed a mitochondrial protein, its large C-terminal domain would likely face the cytosol or the intermembrane space (depending on the exact membrane insertion), positioning it to interact with cytosolic factors or mitochondrial proteins. So far, however, no <strong>mitochondria-specific role</strong> (such as in mitophagy, apoptosis, or mitochondrial lipid metabolism) has been ascribed to PLD5 in the literature. It is also possible that the HPA mitochondrial signal represents a subset of PLD5‚Äôs localization ‚Äî for instance, PLD5 might traffic through the endoplasmic reticulum or endosomes en route to degradation, and some fraction resides on mitochondria. Additional biochemical fractionation studies or colocalization analyses would be needed to confirm the <strong>subcellular compartment(s)</strong> where PLD5 normally functions.</p>
<p>Aside from the mitochondrial hint, by homology one might expect PLD5 to localize to the <strong>endolysosomal system</strong>. PLD3 and PLD4 are known to be sorted to lysosomes (they are type II membrane proteins that undergo lumenal cleavage in lysosomes) (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=While%20crystal%20structures%20for%20RNaseT2,the%20PLD3%20sequence%20contains%20glutamate">academic.oup.com</a>). They function within endosomal/lysosomal lumen to degrade nucleic acids (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>). PLD5 could conceivably follow a similar trafficking route (e.g., from the ER to Golgi and then to endosomes/lysosomes). In fact, early descriptions of PLD3/4/5 referred to them collectively as ‚Äú<strong>TM-type PLDs</strong>‚Äù ‚Äì transmembrane PLDs that lack PX/PH domains and instead have a TM region and a lumenal catalytic domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>). The same 2010 study noted that <strong>‚Äúlittle is known‚Äù</strong> about PLD4, PLD5, and PLD6 at the time (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=now%20officially%20designated%20%E2%80%9CPLD%20family,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>). Over a decade later, PLD4 and PLD6 have had roles uncovered, but PLD5 still eludes clear characterization (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). </p>
<p>From an evolutionary perspective, the presence of PLD5 in mammals (and vertebrates) suggests it has been retained for a reason, even if its classical enzymatic function was lost. <strong>It may act as a catalytically ‚Äúdead‚Äù enzyme that still binds substrate or regulators</strong>, thereby modulating cellular processes. For example, some inactive enzyme relatives function as scaffold proteins or competitive inhibitors of related enzymes. PLD5 might bind phosphatidic acid or other lipids and sequester them, or it might interact with nucleic acids or proteins in a way that influences signaling. This is speculative, but it aligns with the emerging theme that several PLD-family proteins have <strong>non-traditional roles</strong> in cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=While%20crystal%20structures%20for%20RNaseT2,the%20PLD3%20sequence%20contains%20glutamate">academic.oup.com</a>). Further experiments ‚Äì such as identifying binding partners of PLD5, solving its structure, or creating PLD5-knockout models ‚Äì will be needed to unravel its function. As of 2024, PLD5 remains <strong>the least understood member</strong> of the human PLD family.</p>
<h2 id="current-research-and-emerging-insights">Current Research and Emerging Insights</h2>
<p>Research specifically on PLD5 has been limited, but interest is growing as its family members‚Äô importance is recognized. No high-resolution structure or dedicated functional study of PLD5 has been published yet. However, the <strong>latest PLD family reviews</strong> and analyses continue to mention PLD5 as an intriguing ‚Äúorphan‚Äù in terms of function. A 2018 commentary on PLD enzymes highlighted that PLD5 is one of the <strong>incompletely understood isoforms</strong>, noting the uncertainty around its activity (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). In 2023, a structural biology study of PLD3 reiterated the point that PLD5‚Äôs enzymatic status is unknown and little information is available (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). These expert opinions underscore that <strong>PLD5 is an open research question</strong> ‚Äì potentially important, given its conserved presence in mammals, but not yet deciphered. </p>
<p>Experimentally, the most significant recent findings involving PLD5 have come indirectly (e.g. the prostate cancer miR-145 study). Those results suggest PLD5 could be biologically active in certain contexts (promoting cell growth and migration) even if we do not know the mechanism (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>). It raises the possibility that <strong>PLD5 might influence cell signaling pathways</strong>. For instance, PLD5 overexpression was associated with increased AKT phosphorylation in cancer cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>), hinting at a link to the PI3K‚ÄìAKT pathway (a central pro-survival and growth pathway). Whether PLD5 affects this pathway by producing a lipid second messenger or by another means is unclear. It‚Äôs worth noting that classical PLD1/2, when activated, generate phosphatidic acid that can activate mTOR and PKC signaling, driving proliferation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=transmembrane%20domain%20instead%20of%20PX,influenza%20viruses%29%2C%20and%20neurodegenerative">pmc.ncbi.nlm.nih.gov</a>). PLD5, lacking that enzymatic output, might influence signaling in a more indirect way ‚Äì perhaps by binding lipids or signaling proteins. </p>
<p>Another avenue of investigation is <strong>genetic studies</strong>. There are currently no known Mendelian diseases caused by PLD5 mutations, but given its high expression in brain, researchers have looked for links to neurological conditions. As mentioned, one genome-wide study (Anney <em>et al.</em>, 2010) identified a region near <em>PLD5</em> associated with autism spectrum disorder (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=200150#:~:text=Bioengineered%2C%202021%20Dec,association%20to%20chromosome%201q43%20in">www.ncbi.nlm.nih.gov</a>), and another report noted <em>PLD5</em> in a schizophrenia genomic study (though as one of many candidates). These are population-level correlations and do not establish causality, but they make PLD5 a gene of interest for neurodevelopmental function. The <strong>Human Protein Atlas RNA data</strong> showing enrichment in choroid plexus (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/tissue#:~:text=Tissue%20specificity%20%28RNA%29,i%7D%20Evidence%20at%20protein%20level">www.proteinatlas.org</a>) also opens questions about whether PLD5 could relate to cerebrospinal fluid regulation or blood‚Äìbrain barrier processes. </p>
<p>Overall, the current research consensus is that <strong>PLD5 is a catalytically inactive PLD-homolog whose precise role remains to be discovered</strong> (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). Authoritative reviews emphasize prioritizing PLD5 for future study to fill the knowledge gap in the PLD family (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>). As techniques such as CRISPR knockouts, proteomics, and advanced imaging are applied, we expect to learn if PLD5 has a unique substrate (be it a lipid, nucleic acid, or protein) or if it acts as a regulatory scaffold. Its <strong>confirmed presence in membranes and potentially mitochondria</strong> (<a href="https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=Summary,i">www.proteinatlas.org</a>), and its <strong>influence on cellular behaviors</strong> in at least some systems (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>), indicate that PLD5 is not simply nonfunctional. Instead, it likely has a <strong>subtle role in cellular homeostasis or signaling</strong> that has yet to be characterized. Unraveling PLD5‚Äôs function will not only clarify the biology of this particular gene but also enrich our understanding of the diverse strategies that PLD-superfamily proteins use in cell regulation. </p>
<p><strong>References:</strong> Recent literature and reputable databases were used to compile this report. Key sources include primary research articles (e.g., Yoshikawa <em>et al.</em>, 2010 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which">pmc.ncbi.nlm.nih.gov</a>); Nat. Immunology 2018 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal">pmc.ncbi.nlm.nih.gov</a>); Bioengineered 2021 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis">pmc.ncbi.nlm.nih.gov</a>); Nucleic Acids Res. 2023 (<a href="https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment">academic.oup.com</a>)) and curated protein databases (NCBI, UniProt, Human Protein Atlas) for up-to-date information on PLD5. All claims are supported by specific citations throughout the text.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=478, start_index=296, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=biochemical%20mechanism%20and%20an%20H,phosphatidylcholine%20and%20producing%20phosphatidic%20acid')</li>
<li>AnnotationURLCitation(end_index=729, start_index=538, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=instead%20of%20aspartate%20%28HKE%29%20%2822%29,phosphatidylcholine%20and%20producing%20phosphatidic%20acid')</li>
<li>AnnotationURLCitation(end_index=963, start_index=808, title='PLD5 Antibodies | Antibodies.com', type='url_citation', url='https://www.antibodies.com/products/primary-antibodies/pld5-antibodies#:~:text=PLD5%20Antibodies%20Explore%20our%20catalog,Inactive')</li>
<li>AnnotationURLCitation(end_index=1327, start_index=1189, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=1681, start_index=1559, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=1820, start_index=1682, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=2193, start_index=2018, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=now%20officially%20designated%20%E2%80%9CPLD%20family,putative%20TM%20domain%20instead%20of')</li>
<li>AnnotationURLCitation(end_index=2316, start_index=2194, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=2659, start_index=2484, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=5%E2%80%B2%20exonucleases%20PLD3%20or%20PLD4,the%20hydrolysis%20of%20phosphodiester%20bonds')</li>
<li>AnnotationURLCitation(end_index=2798, start_index=2660, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=3165, start_index=3043, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=3502, start_index=3320, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=biochemical%20mechanism%20and%20an%20H,phosphatidylcholine%20and%20producing%20phosphatidic%20acid')</li>
<li>AnnotationURLCitation(end_index=3641, start_index=3503, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=3853, start_index=3731, title='Targeting Phospholipase D4 Attenuates Kidney Fibrosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=,in%20spleen%20and%20early%20postnatal')</li>
<li>AnnotationURLCitation(end_index=4159, start_index=4021, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=4824, start_index=4633, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=instead%20of%20aspartate%20%28HKE%29%20%2822%29,phosphatidylcholine%20and%20producing%20phosphatidic%20acid')</li>
<li>AnnotationURLCitation(end_index=5112, start_index=4977, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=family%20member%205%20,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=5251, start_index=5113, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=5591, start_index=5469, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=5886, start_index=5731, title='PLD5 Antibodies | Antibodies.com', type='url_citation', url='https://www.antibodies.com/products/primary-antibodies/pld5-antibodies#:~:text=PLD5%20Antibodies%20Explore%20our%20catalog,Inactive')</li>
<li>AnnotationURLCitation(end_index=6339, start_index=6217, title='Targeting Phospholipase D4 Attenuates Kidney Fibrosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=,in%20spleen%20and%20early%20postnatal')</li>
<li>AnnotationURLCitation(end_index=6536, start_index=6414, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=7103, start_index=6942, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=7277, start_index=7104, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=While%20crystal%20structures%20for%20RNaseT2,the%20PLD3%20sequence%20contains%20glutamate')</li>
<li>AnnotationURLCitation(end_index=7564, start_index=7431, title='eProteinWorkbench', type='url_citation', url='https://eprotworkbench.apps.cloud.kbds.re.kr/hProteome-7.L-R.html#:~:text=Q8N7P1%20%20,link')</li>
<li>AnnotationURLCitation(end_index=7839, start_index=7678, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=8015, start_index=7882, title='eProteinWorkbench', type='url_citation', url='https://eprotworkbench.apps.cloud.kbds.re.kr/hProteome-7.L-R.html#:~:text=Q8N7P1%20%20,link')</li>
<li>AnnotationURLCitation(end_index=8317, start_index=8151, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=8617, start_index=8451, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=9537, start_index=9359, title='Targeting Phospholipase D4 Attenuates Kidney Fibrosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=transmembrane%20domain%20instead%20of%20PX,influenza%20viruses%29%2C%20and%20neurodegenerative')</li>
<li>AnnotationURLCitation(end_index=9836, start_index=9698, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=10268, start_index=10107, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=10570, start_index=10409, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=11311, start_index=11149, title='Tissue expression of PLD5 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/tissue#:~:text=Tissue%20specificity%20%28RNA%29,i%7D%20Evidence%20at%20protein%20level')</li>
<li>AnnotationURLCitation(end_index=11650, start_index=11488, title='Tissue expression of PLD5 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/tissue#:~:text=Tissue%20specificity%20%28RNA%29,i%7D%20Evidence%20at%20protein%20level')</li>
<li>AnnotationURLCitation(end_index=12047, start_index=11870, title='PLD5 phospholipase D family member 5 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=200150#:~:text=Bioengineered%2C%202021%20Dec,association%20to%20chromosome%201q43%20in')</li>
<li>AnnotationURLCitation(end_index=12708, start_index=12523, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=13083, start_index=12898, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=13432, start_index=13247, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=13547, start_index=13433, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=3,145%20in%20prostate%20cancer')</li>
<li>AnnotationURLCitation(end_index=13881, start_index=13696, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=14340, start_index=14155, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=14467, start_index=14341, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=incubated%20with%20anti,The%20bands%20were')</li>
<li>AnnotationURLCitation(end_index=15482, start_index=15336, title='PLD5 gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/summary/gene#:~:text=Synonyms%20FLJ40773%20Gene%20description,i%7D%204')</li>
<li>AnnotationURLCitation(end_index=15755, start_index=15609, title='PLD5 gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/summary/gene#:~:text=Synonyms%20FLJ40773%20Gene%20description,i%7D%204')</li>
<li>AnnotationURLCitation(end_index=15989, start_index=15872, title='Subcellular - PLD5 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=Main%20location,cycle')</li>
<li>AnnotationURLCitation(end_index=16262, start_index=16151, title='Subcellular - PLD5 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=HPA028389%20A,i')</li>
<li>AnnotationURLCitation(end_index=16534, start_index=16417, title='Subcellular - PLD5 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=Main%20location,cycle')</li>
<li>AnnotationURLCitation(end_index=16949, start_index=16816, title='eProteinWorkbench', type='url_citation', url='https://eprotworkbench.apps.cloud.kbds.re.kr/hProteome-7.L-R.html#:~:text=Q8N7P1%20%20,link')</li>
<li>AnnotationURLCitation(end_index=18196, start_index=18023, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=While%20crystal%20structures%20for%20RNaseT2,the%20PLD3%20sequence%20contains%20glutamate')</li>
<li>AnnotationURLCitation(end_index=18431, start_index=18270, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=18872, start_index=18750, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=19132, start_index=18966, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=now%20officially%20designated%20%E2%80%9CPLD%20family,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=19406, start_index=19240, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=20289, start_index=20128, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=20463, start_index=20290, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=While%20crystal%20structures%20for%20RNaseT2,the%20PLD3%20sequence%20contains%20glutamate')</li>
<li>AnnotationURLCitation(end_index=21415, start_index=21249, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=21724, start_index=21558, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=22361, start_index=22176, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=22729, start_index=22544, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=23248, start_index=23070, title='Targeting Phospholipase D4 Attenuates Kidney Fibrosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5698063/#:~:text=transmembrane%20domain%20instead%20of%20PX,influenza%20viruses%29%2C%20and%20neurodegenerative')</li>
<li>AnnotationURLCitation(end_index=23930, start_index=23753, title='PLD5 phospholipase D family member 5 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=200150#:~:text=Bioengineered%2C%202021%20Dec,association%20to%20chromosome%201q43%20in')</li>
<li>AnnotationURLCitation(end_index=24412, start_index=24250, title='Tissue expression of PLD5 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/tissue#:~:text=Tissue%20specificity%20%28RNA%29,i%7D%20Evidence%20at%20protein%20level')</li>
<li>AnnotationURLCitation(end_index=24843, start_index=24677, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=25122, start_index=24956, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
<li>AnnotationURLCitation(end_index=25516, start_index=25411, title='Subcellular - PLD5 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180287-PLD5/subcellular#:~:text=Summary,i')</li>
<li>AnnotationURLCitation(end_index=25772, start_index=25587, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=26443, start_index=26305, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=%5B21%5D%20.%20Human%20Hu,of%20PX%20and%20PH%20domains')</li>
<li>AnnotationURLCitation(end_index=26566, start_index=26444, title='Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2978679/#:~:text=to%20as%20TM,PDE2%20domains%2C%20which')</li>
<li>AnnotationURLCitation(end_index=26750, start_index=26589, title='PLD3 and PLD4 are single stranded acid exonucleases that regulate endosomal nucleic acid sensing - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6105523/#:~:text=nucleic%20acid%20sensing%20,acid%20exonucleases%20that%20regulate%20endosomal')</li>
<li>AnnotationURLCitation(end_index=26956, start_index=26771, title='MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8806496/#:~:text=tissues%20in%20comparison%20to%20the,proliferation%2C%20migration%2C%20invasion%2C%20and%20metastasis')</li>
<li>AnnotationURLCitation(end_index=27148, start_index=26982, title='Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5‚Ä≤ exonuclease-mediated nucleic acid degradation | Nucleic Acids Research | Oxford Academic', type='url_citation', url='https://academic.oup.com/nar/article/52/1/370/7442542#:~:text=intracellular%20signaling%20pathways,also%20contains%20a%20transmembrane%20segment')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q8N7P1
gene_symbol: PLD5
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  Phospholipase D family member 5 (PLD5) is a poorly characterized member of
  the PLD superfamily. Despite containing the characteristic PLD phosphodiesterase
  domains with HKD motifs, PLD5 is considered catalytically inactive as a
  phospholipase because it lacks conserved active site residues required for
  phospholipid hydrolysis. UniProt explicitly names this protein &#34;Inactive
  phospholipase D5&#34;. The protein is a type II single-pass transmembrane protein
  (~536 amino acids, ~61 kDa) that lacks the PX and PH domains found in classical
  PLD1/PLD2. Expression is enriched in brain and choroid plexus. Subcellular
  localization studies suggest mitochondrial localization in some cell types.
  While related family members PLD3/PLD4 have been shown to function as 5&#39;
  exonucleases in endolysosomes rather than lipases, no enzymatic activity has
  been demonstrated for PLD5. The molecular function of PLD5 remains undefined -
  it may act as a pseudoenzyme/scaffold, have an unknown substrate, or possess
  a non-catalytic regulatory role. Overexpression in prostate cancer promotes
  proliferation and is regulated by miR-145-5p. PLD5 is distinct from PLD6/MitoPLD
  which has cardiolipin hydrolase activity.
existing_annotations:
- term:
    id: GO:0003824
    label: catalytic activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      This annotation is based on InterPro domain IPR001736 (PLipase_D/transphosphatidylase)
      which is present in PLD5. However, authoritative reviews and UniProt explicitly
      state that PLD5 lacks the conserved HKD active sites and is catalytically inactive.
    action: REMOVE
    reason: &gt;-
      PLD5 is explicitly designated as &#34;Inactive phospholipase D5&#34; by UniProt due to
      degenerate HKD catalytic motifs. Multiple reviews confirm PLD5 lacks phospholipase
      activity. Nelson and Frohman (2015) state PLD5 has &#34;no catalytic activity&#34; as a
      lipase. Bozatzi and Sapkota (2018) confirm PLD5 is &#34;catalytically inactive&#34; due to
      lacking HKD motifs. A 2023 structural analysis states &#34;Little is known about PLD5,
      and it is even unclear if it is active as an enzyme.&#34; While the protein contains
      the PLD domain architecture, this IEA annotation incorrectly implies active
      catalytic function. The presence of a catalytic domain does not guarantee
      enzymatic activity - many pseudoenzymes exist.
    supported_by:
    - reference_id: file:human/PLD5/PLD5-uniprot.txt
      supporting_text: &gt;-
        In contrast to other members of the family, it lacks the
        conserved active sites, suggesting that it has no phospholipase
        activity.
    - reference_id: file:human/PLD5/PLD5-deep-research-falcon.md
      supporting_text: &gt;-
        PLD5 catalytic status: Authoritative reviews consistently report that human PLD5 lacks catalytic activity as a lipase because it lacks the requisite conserved HKD catalytic motifs; thus PLD5 is considered catalytically inactive within the classical PLD reaction framework
    - reference_id: file:human/PLD5/PLD5-deep-research-openai.md
      supporting_text: &gt;-
        PLD5 is often referred to as an &#34;inactive phospholipase D5&#34; in databases
- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &gt;-
      PLD5 is a single-pass type II transmembrane protein with a predicted
      transmembrane helix at residues 69-89. UniProt confirms membrane
      localization, and HPA data suggests mitochondrial membrane localization.
    action: MODIFY
    reason: &gt;-
      While the general membrane annotation is correct, more specific localization
      data is available. Human Protein Atlas immunofluorescence data shows PLD5
      is primarily localized to mitochondria in U-2 OS and A-549 cell lines.
      The protein has a single transmembrane domain consistent with a type II
      membrane topology. More specific annotations for intracellular membrane
      or mitochondrial membrane would be more informative.
    proposed_replacement_terms:
    - id: GO:0016021
      label: integral component of membrane
    - id: GO:0031966
      label: mitochondrial membrane
    supported_by:
    - reference_id: file:human/PLD5/PLD5-uniprot.txt
      supporting_text: &gt;-
        SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
        protein {ECO:0000305}.
    - reference_id: file:human/PLD5/PLD5-deep-research-openai.md
      supporting_text: &gt;-
        Data from the Human Protein Atlas indicate PLD5 is primarily localized to mitochondria in cultured human cells
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms.
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping.
  findings: []
- id: file:human/PLD5/PLD5-uniprot.txt
  title: UniProtKB entry for human PLD5 (Inactive phospholipase D5)
  findings:
  - statement: Explicitly named &#34;Inactive phospholipase D5&#34; with caution note about lacking conserved active sites
    supporting_text: &gt;-
      RecName: Full=Inactive phospholipase D5
  - statement: Single-pass transmembrane protein, 536 amino acids
    supporting_text: &gt;-
      TRANSMEM        69..89
  - statement: Contains two PLD phosphodiesterase domains
    supporting_text: &gt;-
      DOMAIN          215..242 ... PLD phosphodiesterase 1 ... DOMAIN          434..460 ... PLD phosphodiesterase 2
  - statement: Expression enriched in brain and choroid plexus
    supporting_text: &gt;-
      HPA; ENSG00000180287; Group enriched (brain, choroid plexus).
- id: file:human/PLD5/PLD5-deep-research-falcon.md
  title: Deep research report on PLD5 from Falcon/Edison Scientific Literature
  findings:
  - statement: PLD5 lacks catalytic activity as a lipase due to missing HKD motifs
    supporting_text: &gt;-
      PLD5 catalytic status: Authoritative reviews consistently report that human PLD5 lacks catalytic activity as a lipase because it lacks the requisite conserved HKD catalytic motifs; thus PLD5 is considered catalytically inactive within the classical PLD reaction framework
  - statement: PLD5 may have non-lipase activity similar to PLD3/PLD4 which are nucleases
    supporting_text: &gt;-
      some paralogs (e.g., PLD3) possess nuclease activity rather than phospholipase activity, underscoring divergent functions within the family
  - statement: PLD5 overexpression promotes cancer cell proliferation
    supporting_text: &gt;-
      PLD5 overexpression promotes proliferation, migration, invasion, and metastasis, whereas miR-145-5p mimics suppress these PLD5-driven oncogenic phenotypes
- id: file:human/PLD5/PLD5-deep-research-openai.md
  title: Deep research report on PLD5 from OpenAI o3-deep-research
  findings:
  - statement: PLD5 is a transmembrane protein with type II membrane topology
    supporting_text: &gt;-
      PLD5 contains a short N-terminal segment, a single-pass transmembrane region, and a large C-terminal region comprising two PLD phosphodiesterase domains
  - statement: PLD5 localizes to mitochondria in cultured cells
    supporting_text: &gt;-
      Data from the Human Protein Atlas indicate PLD5 is primarily localized to mitochondria in cultured human cells
  - statement: No enzymatic activity has been demonstrated for PLD5
    supporting_text: &gt;-
      Little is known about PLD5, and it is even unclear if it is active as an enzyme
aliases:
- Inactive phospholipase D5
- Inactive PLD 5
- Inactive choline phosphatase 5
- PLDc
- Phospholipase D family member 5
core_functions:
- molecular_function:
    id: GO:0003674
    label: molecular_function
  description: &gt;-
    PLD5 molecular function is undefined. The protein contains PLD phosphodiesterase
    domains but lacks conserved active site residues for phospholipase activity.
    It may function as a pseudoenzyme with scaffolding or regulatory roles rather
    than catalytic activity. The protein contains two PLDc domains that could
    potentially bind substrates or interaction partners without catalyzing reactions.
    No specific binding partners or activities have been experimentally validated.
    Unlike PLD3/PLD4 which have been shown to have nuclease activity, PLD5 has
    no demonstrated enzymatic activity of any kind.
  locations:
  - id: GO:0031966
    label: mitochondrial membrane
  - id: GO:0016021
    label: integral component of membrane
  directly_involved_in: []
  supported_by:
  - reference_id: file:human/PLD5/PLD5-uniprot.txt
    supporting_text: &gt;-
      In contrast to other members of the family, it lacks the
      conserved active sites, suggesting that it has no phospholipase
      activity.
  - reference_id: file:human/PLD5/PLD5-deep-research-openai.md
    supporting_text: &gt;-
      Little is known about PLD5, and it is even unclear if it is active as an enzyme
proposed_new_terms: []
suggested_questions:
- question: Does PLD5 have any enzymatic activity (e.g., nuclease activity like PLD3/PLD4, or other non-phospholipase activity)?
- question: What is the functional significance of PLD5 mitochondrial localization?
- question: Does PLD5 function as a pseudoenzyme/scaffold by binding substrates or regulators without catalyzing reactions?
- question: What are the binding partners of PLD5?
- question: Why is PLD5 expression enriched in brain/choroid plexus?
suggested_experiments:
- description: In vitro biochemical assays testing PLD5 for nuclease activity (as seen in PLD3/PLD4) and other potential enzymatic activities
  hypothesis: PLD5 may have nuclease activity similar to its paralogs PLD3/PLD4
  experiment_type: biochemical assay
- description: Co-immunoprecipitation followed by mass spectrometry to identify PLD5 protein interaction partners
  hypothesis: PLD5 may function as a scaffold by interacting with other proteins
  experiment_type: proteomics
- description: CRISPR knockout of PLD5 in neuronal or choroid plexus cell lines to assess phenotypes
  hypothesis: Loss of PLD5 may reveal its function in brain-enriched tissues
  experiment_type: functional genomics
- description: Structural studies (X-ray crystallography or cryo-EM) to determine if PLD5 active site can accommodate substrates
  hypothesis: Structural analysis may reveal whether PLD5 can bind substrates despite lacking catalytic activity
  experiment_type: structural biology
- description: Submitochondrial fractionation to determine precise membrane localization (outer vs inner mitochondrial membrane)
  hypothesis: Precise localization may suggest functional context
  experiment_type: cell biology
status: COMPLETE
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>